Evidence map›Paper›PMID 33820812›Full record

ArticleInfection and immunity2021

The Small Molecule H89 Inhibits

Karissa J Muñoz, Kevin Wang, Lauren M Sheehan, Ming Tan, Christine Sütterlin

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Pyocyanin reversibly inhibitsFrontiers in pharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Alternative strategies forFrontiers in microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Karissa J MuñozDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
Kevin WangDepartment of Microbiology and Molecular Genetics, University of California, Irvine, California, USA.
Lauren M SheehanDepartment of Microbiology and Molecular Genetics, University of California, Irvine, California, USA.
Ming TanDepartment of Microbiology and Molecular Genetics, University of California, Irvine, California, USA.
Christine SütterlinDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
University of California, Irvine · US

Funding

The Regulation of gene expression in ChlamydiaR01AI044198 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI TAN, MING · 1999 to 2021
$7.1M
Mechanism of RB-to-EB Conversion in ChlamydiaR01AI151212 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI BOASSA, DANIELA, ENCISO, GERMAN ANDRES · 2020 to 2024
$3.5M
Primary cilia loss and cell cycle re-entry in Chlamydia-infected cellsR01AI153410 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI SUETTERLIN, CHRISTINE, TAN, MING · 2020 to 2024
$3.0M
T32 for Training in Microbiology & Infectious DiseasesT32AI141346 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI Celia Goulding, Melissa Bruckner Lodoen · 2019 to 2026
$1.0M
NIAID NIH HHS R01 AI044198NIAID NIH HHS R01 AI151212NIAID NIH HHS R01 AI153410NIAID NIH HHS T32 AI141346
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsChlamydiaChlamydia InfectionsDose-Response Relationship, DrugGene Expression Regulation, BacterialHumansIsoquinolinesSulfonamidesAnti-Bacterial AgentsBacterial ProteinsIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideSulfonamidesdevelopmental cycleintracellular infectionisoquinoline sulfonamideRB-to-EB conversion

Identifiers

PMID33820812
PMCPMC8373235
OpenAlexW3147065072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.